Jeffrey Berkowitz - 26 May 2022 Form 4 Insider Report for Esperion Therapeutics, Inc. (ESPR)

Role
Director
Signature
/s/ Sheldon L. Koenig, by power of attorney
Issuer symbol
ESPR
Transactions as of
26 May 2022
Transactions value $
$0
Form type
4
Filing time
27 May 2022, 16:20:25 UTC
Previous filing
28 May 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ESPR Stock Option (right to buy) Award $0 +20K $0.00 20K 26 May 2022 Common Stock 20K $5.51 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The awards vest in full on the earlier of (i) May 26, 2023 and (ii) the Issuer's next annual meeting of stockholders following May 26, 2022.